|
|
Volumn 37, Issue 1, 2005, Pages 130-133
|
|
The novel antifibrotic agent pirfenidone attenuates the profibrotic environment generated by calcineurin inhibitors in the rat salt-depletion model
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIFIBROTIC AGENT;
CALCINEURIN INHIBITOR;
COLLAGEN TYPE 3;
CREATININE;
CYCLOSPORIN;
GELATINASE A;
MESSENGER RNA;
PIRFENIDONE;
PROTEIN;
TACROLIMUS;
TISSUE INHIBITOR OF METALLOPROTEINASE 1;
TRANSFORMING GROWTH FACTOR BETA;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
CONFERENCE PAPER;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DISSOCIATION;
DOSE RESPONSE;
DRUG EFFECT;
DRUG MECHANISM;
EXTRACELLULAR MATRIX;
GENE EXPRESSION;
HISTOPATHOLOGY;
KIDNEY FIBROSIS;
MALE;
NEPHROTOXICITY;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN URINE LEVEL;
QUANTITATIVE ANALYSIS;
RAT;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
SODIUM DEPLETION;
STATISTICAL SIGNIFICANCE;
URINARY EXCRETION;
|
|
EID: 16244422029
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.12.150 Document Type: Conference Paper |
|
Times cited : (17)
|
|
References (7)
|
